Regulus Therapeutics Inc.
RGLS
Revenue
0.00
0.000.00%
3 Months ChangeAssets
84.18M
▼-9.58M▼-10.22%
3 Months ChangeLiabilities
7.77M
▲815.00k▲11.71%
3 Months ChangeFree Cash Flow
-8.97M
▼-856.00k▼-10.55%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-24
Form 8-K
ID: 0001193125-24-242801
2024-08-08
Form 10-Q
ID: 0001628280-24-036174
2024-08-08
Form 8-K
ID: 0001193125-24-196977
2024-06-24
Form 8-K
ID: 0001193125-24-166299
2024-05-17
Form 8-K
ID: 0001193125-24-141703
2024-05-09
Form 10-Q
ID: 0001628280-24-022266
2024-05-09
Form 8-K
ID: 0001193125-24-135281
2024-03-21
Form 8-K
ID: 0001193125-24-073858
2024-03-14
Form 8-K
ID: 0001193125-24-068000
2023-11-09
Form 10-Q
ID: 0001628280-23-038295